Loss-of-Function Versus Toxic Gain-of-Function Hypotheses in Mutant SOD1

• Headline: Unraveling Mutant SOD1 Toxicity: Loss-of-Function vs. Toxic Gain-of-Function Models

• Introduction: Understanding whether mutant SOD1 causes motor neuron degeneration via a loss of normal enzymatic activity or through a toxic gain of function has driven decades of mechanistic research. Transgenic mouse and cellular models have conclusively shifted the scientific consensus toward downstream toxic gain-of-function paradigms.

• Mechanistic Evidence:

  • Loss-of-Function Refutation: Mice engineered with complete genetic nulls for SOD1 do not develop amyotrophic lateral sclerosis, proving that mere loss of superoxide dismutase activity is insufficient to cause the disease.

  • Gain-of-Function Confirmation: Mice expressing mutant human SOD1 alongside normal endogenous mouse SOD1 successfully replicate the full clinical and pathological phenotype of ALS.

• Downstream Cellular Disruptions:

  • Aberrant oxidative chemistry from inappropriate substrate binding.

  • Formation of misfolded protein aggregates that sequester vital chaperones (like HSP70) and clog the 20S proteasome.